To characterize whether the differences in the level of TrkB were associated with differences in tumor histology, we first investigated the clinical relevance using public HCC microarray datasets to interrogate the correlation between the expression of TrkB and the progression of HCC. The gene discussed is NTRK2; the disease is hepatocellular carcinoma.